Graphium Biosciences, Inc. announced that it has received $4 million in a round of funding on December 7, 2023. The transaction includes the participation from new investor, Range Impact, Inc.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3 USD | 0.00% |
|
-8.26% | +11.11% |
05-15 | Range Impact, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-26 | Range Impact, Inc. Announces Executive Changes | CI |
1st Jan change | Capi. | |
---|---|---|
+11.11% | 30.31M | |
+15.82% | 83.43B | |
+16.08% | 60.42B | |
+22.22% | 24.99B | |
+29.37% | 12.24B | |
+24.98% | 11.11B | |
-3.43% | 6.53B | |
+21.14% | 4.84B | |
+22.71% | 4.72B | |
-15.74% | 2.67B |
- Stock Market
- Equities
- RNGE Stock
- News Range Impact, Inc.
- Graphium Biosciences, Inc. announced that it expects to receive $4 million in funding from Range Impact, Inc.